Search:
 

Price

Market

Sector

Market Cap

188.25p (-0.25p) -0.13% Down LSE Medicine and Biotech Research £273.92m
Articles Financial Data Charts Profile
Related Companies

Recent Articles

Acambis 21/01/2008
TECHMARK Report 31/03/2003
Drug-induced investments 30/04/2002
techMARK Report 26/03/2002
Acambis wins $428m smallpox contract 29/11/2001
Acambis 01/08/2001
Acambis 28/06/2001
Acambis 16/03/2001
Acambis 12/02/2001
Peptide Therapeutics 20/09/2000
More

Recent Announcements

Articles from the Sector

Financial History

Financial Year End 31/12/2003 31/12/2004 31/12/2005 31/12/2006 31/12/2007
Currency GBP GBP GBP GBP GBP
Turnover 169.10 85.50 40.90 30.90 9.50
Operating Profit 45.00 23.10 -30.70 -17.20 -32.30
Pretax Profit 39.60 27.00 -27.70 -15.90 -31.30
Earnings After Tax 35.70 19.70 -27.00 -16.50 -31.30
Profit Available For Dividend 0.00 0.00 0.00 0.00 0.00
Ordinary Dividends 0.00 0.00 0.00 0.00 0.00
Retained Profit 35.70 0.00 0.00 0.00 0.00
Shareholders Funds 86.50 107.50 83.00 65.10 35.30
Net Current Assets 58.90 0.00 0.00 0.00 0.00
Adjusted Earnings Per Share Undiluted 0.00 18.50 -25.20 -15.40 -29.00
Adj Earnings Per Share 0.00 18.10 -25.20 -15.40 -29.00
Dividend Per Share 0.00 0.00 0.00 0.00 0.00

Company Details

Address
Telephone
Fax

Advisers

Nominated Adviser
Nominated Broker
Solicitors
Auditors
Registrar

Company Data

Code ACM
Sedol GB00069417
Shares In Issue 145.510 m
Indices
Entry on AIM
Interim Results
Final Results
Year End
Accounts Due
Int div payment
Fin div payment
Int net div per share
Fin net div per share
Probable CGT relief